Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC)
Restricted accessResearch articleFirst published online May, 2019
Exercise training for patients with type 2 diabetes and cardiovascular disease: What to pursue and how to do it. A Position Paper of the European Association of Preventive Cardiology (EAPC)
Patients with type 2 diabetes mellitus suffer from dysregulation of a plethora of cardiovascular and metabolic functions, including dysglycaemia, dyslipidaemia, arterial hypertension, obesity and a reduced cardiorespiratory fitness. Exercise training has the potential to improve many of these functions, such as insulin sensitivity, lipid profile, vascular reactivity and cardiorespiratory fitness, particularly in type 2 diabetes mellitus patients with cardiovascular comorbidities, such as patients that suffered from an acute myocardial infarction, or after a coronary intervention such as percutaneous coronary intervention or coronary artery bypass grafting. The present position paper aims to provide recommendations for prescription of exercise training in patients with both type 2 diabetes mellitus and cardiovascular disease. The first part discusses the relevance and practical applicability of treatment targets that may be pursued, and failure to respond to these targets. The second part provides recommendations on the contents and methods to prescribe exercise training tailored to these treatment targets as well as to an optimal preparation and dealing with barriers and risks specific to type 2 diabetes mellitus and cardiac comorbidity.
BeckmanJAPaneniFCosentinoFet al.Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J2013; 34: 2444–2452.
Krankel N, Bahls M, Van Craenenbroeck EM, et al. Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work? Eur J Prev Cardiol. 2019; 26: 701–708.
4.
MorratoEHHillJOWyattHRet al.Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care2007; 30: 203–209.
5.
AdeniyiAFAnjanaRMWeberMB. Global account of barriers and facilitators of physical activity among patients with diabetes mellitus: A narrative review of the literature. Curr Diabetes Rev2016; 12: 440–448.
6.
PandeyASwiftDLMcGuireDKet al.Metabolic effects of exercise training among fitness-nonresponsive patients with type 2 diabetes: The HART-D study. Diabetes Care2015; 38: 1494–1501.
7.
MalandrinoMIFuchoRWeberMet al.Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. Am J Physiol Endocrinol Metab2015; 308: E756–E769.
8.
ThomasDEElliottEJNaughtonGA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev2006; 19(3): CD002968–CD002968.
9.
Koster-RasmussenRSimonsenMKSiersmaVet al.Intentional weight loss and longevity in overweight patients with type 2 diabetes: a population-based cohort study. PLoS One2016; 11: e0146889–e0146889.
10.
BalducciSZanusoSCardelliPet al.Changes in physical fitness predict improvements in modifiable cardiovascular risk factors independently of body weight loss in subjects with type 2 diabetes participating in the Italian Diabetes and Exercise Study (IDES). Diabetes Care2012; 35: 1347–1354.
11.
SchwingshacklLMissbachBDiasSet al.Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: A systematic review and network meta-analysis. Diabetologia2014; 57: 1789–1797.
12.
ChudykAPetrellaRJ. Effects of exercise on cardiovascular risk factors in type 2 diabetes: A meta-analysis. Diabetes Care2011; 34: 1228–1237.
13.
YangZScottCAMaoCet al.Resistance exercise versus aerobic exercise for type 2 diabetes: A systematic review and meta-analysis. Sports Med2014; 44: 487–499.
14.
UmpierreDRibeiroPASchaanBDet al.Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: A systematic review with meta-regression analysis. Diabetologia2013; 56: 242–251.
15.
OliveiraCSimoesMCarvalhoJet al.Combined exercise for people with type 2 diabetes mellitus: A systematic review. Diabetes Res Clin Pract2012; 98: 187–198.
16.
MitranunWDeerochanawongCTanakaHet al.Continuous vs interval training on glycemic control and macro- and microvascular reactivity in type 2 diabetic patients. Scand J Med Sci Sports2014; 24: e69–e76.
VinettiGMozziniCDesenzaniPet al.Supervised exercise training reduces oxidative stress and cardiometabolic risk in adults with type 2 diabetes: a randomized controlled trial. Scientific reports2015; 5: 9238–9238.
19.
LucottiPMontiLDSetolaEet al.Aerobic and resistance training effects compared to aerobic training alone in obese type 2 diabetic patients on diet treatment. Diabetes Res Clin Pract2011; 94: 395–403.
20.
HamasakiHKawashimaYTamadaYet al.Associations of low-intensity resistance training with body composition and lipid profile in obese patients with type 2 diabetes. PLoS One2015; 10: e0132959–e0132959.
21.
HerbstAKapellenTSchoberEet al.Impact of regular physical activity on blood glucose control and cardiovascular risk factors in adolescents with type 2 diabetes mellitus – a multicenter study of 578 patients from 225 centres. Pediatr Diabetes2015; 16: 204–210.
22.
MendhamAEDuffieldRMarinoFet al.A 12-week sports-based exercise programme for inactive Indigenous Australian men improved clinical risk factors associated with type 2 diabetes mellitus. J Sci Med Sport2015; 18: 438–443.
23.
ThompsonDWalhinJPBatterhamAMet al.Effect of diet or diet plus physical activity versus usual care on inflammatory markers in patients with newly diagnosed type 2 diabetes: The Early ACTivity in Diabetes (ACTID) randomized, controlled trial. J Am Heart Assoc2014; 3: e000828–e000828.
24.
LiuYLiuSXCaiYet al.Effects of combined aerobic and resistance training on the glycolipid metabolism and inflammation levels in type 2 diabetes mellitus. J Phys Ther Sci2015; 27: 2365–2371.
25.
Molanouri ShamsiMHassanZHGharakhanlouRet al.Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: Effect of resistance exercise training. Endocrine2014; 46: 60–69.
26.
HoppsECaninoBCaimiG. Effects of exercise on inflammation markers in type 2 diabetic subjects. Acta Diabetol2011; 48: 183–189.
27.
MyersJPrakashMFroelicherVet al.Exercise capacity and mortality among men referred for exercise testing. N Engl J Med2002; 346: 793–801.
28.
KeteyianSJBrawnerCASavagePDet al.Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J2008; 156: 292–300.
29.
ModenaMGBonettiLCoppiFet al.Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol2002; 40: 505–510.
30.
KittaYObataJENakamuraTet al.Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol2009; 53: 323–330.
31.
MonteroDWaltherGBenamoEet al.Effects of exercise training on arterial function in type 2 diabetes mellitus: A systematic review and meta-analysis. Sports Med2013; 43: 1191–1199.
32.
MatsuzawaYGuddetiRRKwonTGet al.Treating coronary disease and the impact of endothelial dysfunction. Progr Cardiovasc Dis2015; 57: 431–442.
33.
GielenSLaughlinMHO’ConnerCet al.Exercise training in patients with heart disease: Review of beneficial effects and clinical recommendations. Progr Cardiovasc Dis2015; 57: 347–355.
34.
GielenSSchulerGHambrechtR. Exercise training in coronary artery disease and coronary vasomotion. Circulation2001; 103: E1–E6.
35.
HambrechtRWolfAGielenSet al.Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med2000; 342: 454–460.
36.
HuebschmannAGKohrtWMRegensteinerJG. Exercise attenuates the premature cardiovascular aging effects of type 2 diabetes mellitus. Vasc Med2011; 16: 378–390.
37.
SchreuderTHMaessenMFTackCJet al.Life-long physical activity restores metabolic and cardiovascular function in type 2 diabetes. Eur J Appl Physiol2014; 114: 619–627.
38.
SchreuderTHvan den MunckhofIPoelkensFet al.Combined aerobic and resistance exercise training decreases peripheral but not central artery wall thickness in subjects with type 2 diabetes. Eur J Appl Physiol2015; 115: 317–326.
39.
KalyaniRRCorriereMFerrucciL. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol2014; 2: 819–829.
40.
SenechalMJohannsenNMSwiftDLet al.Association between changes in muscle quality with exercise training and changes in cardiorespiratory fitness measures in individuals with type 2 diabetes mellitus: Results from the HART-D Study. PLoS One2015; 10: e0135057–e0135057.
41.
ChenLPeiJHKuangJet al.Effect of lifestyle intervention in patients with type 2 diabetes: A meta-analysis. Metabolism2015; 64: 338–347.
42.
FigueiraFRUmpierreDCureauFVet al.Association between physical activity advice only or structured exercise training with blood pressure levels in patients with type 2 diabetes: A systematic review and meta-analysis. Sports Med2014; 44: 1557–1572.
43.
DobrosielskiDAGibbsBBOuyangPet al.Effect of exercise on blood pressure in type 2 diabetes: A randomized controlled trial. J Gen Intern Med2012; 27: 1453–1459.
44.
MobasseriMYavariANajafipoorFet al.Effect of a long-term regular physical activity on hypertension and body mass index in type 2 diabetes patients. J Sports Med Phys Fitness2015; 55: 84–90.
45.
HoworkaKPumprlaJHaberPet al.Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res1997; 34: 206–214.
46.
SacreJWJellisCLJenkinsCet al.A six-month exercise intervention in subclinical diabetic heart disease: Effects on exercise capacity, autonomic and myocardial function. Metabolism2014; 63: 1104–1114.
47.
VoulgariCPagoniSVinikAet al.Exercise improves cardiac autonomic function in obesity and diabetes. Metabolism2013; 62: 609–621.
48.
ChurchTSChengYJEarnestCPet al.Exercise capacity and body composition as predictors of mortality among men with diabetes. Diabetes Care2004; 27: 83–88.
49.
ChurchTSBlairSNCocrehamSet al.Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: A randomized controlled trial. JAMA2010; 304: 2253–2262.
50.
LookARGWingRR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: Four-year results of the Look AHEAD trial. Arch Intern Med2010; 170: 1566–1575.
51.
KarstoftKWindingKKnudsenSHet al.The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients: A randomized, controlled trial. Diabetes Care2013; 36: 228–236.
52.
LookARGWingRRBolinPet al.Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med2013; 369: 145–154.
53.
BouleNGHaddadEKennyGPet al.Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: A meta-analysis of controlled clinical trials. JAMA2001; 286: 1218–1227.
54.
LuleyCBlaikAReschkeKet al.Weight loss in obese patients with type 2 diabetes: Effects of telemonitoring plus a diet combination – the Active Body Control (ABC) Program. Diabetes Res Clin Pract2011; 91: 286–292.
55.
McAuleyPAMyersJNAbellaJPet al.Exercise capacity and body mass as predictors of mortality among male veterans with type 2 diabetes. Diabetes Care2007; 30: 1539–1543.
56.
KavanaghTMertensDJHammLFet al.Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation2002; 106: 666–671.
57.
KavanaghTMertensDJHammLFet al.Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol2003; 42: 2139–2143.
58.
LeeDCSuiXArteroEGet al.Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men: The Aerobics Center Longitudinal Study. Circulation2011; 124: 2483–2490.
59.
StewartRAHHeldCHadziosmanovicNet al.Physical activity and mortality in patients with stable coronary heart disease. J Am Coll Cardiol2017; 70: 1689–1700.
60.
SchreuderTHGreenDJNyakayiruJet al.Time-course of vascular adaptations during 8 weeks of exercise training in subjects with type 2 diabetes and middle-aged controls. Eur J Appl Physiol2015; 115: 187–196.
61.
OkadaSHiugeAMakinoHet al.Effect of exercise intervention on endothelial function and incidence of cardiovascular disease in patients with type 2 diabetes. J Atheroscler Thromb2010; 17: 828–833.
62.
SixtSBeerSBluherMet al.Long- but not short-term multifactorial intervention with focus on exercise training improves coronary endothelial dysfunction in diabetes mellitus type 2 and coronary artery disease. Eur Heart J2010; 31: 112–119.
63.
BouleNGKennyGPHaddadEet al.Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia2003; 46: 1071–1081.
64.
HansenDDendalePConinxKet al.The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. Eur J Prev Cardiol2017; 24: 1017–1031.
65.
Van SluijsEMvan PoppelMNTwiskJWet al.Physical activity measurements affected participants’ behavior in a randomized controlled trial. J Clin Epidemiol2006; 59: 404–411.
66.
UmpierreDRibeiroPAKramerCKet al.Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: A systematic review and meta-analysis. JAMA2011; 305: 1790–1799.
67.
StrasserBPestaD. Resistance training for diabetes prevention and therapy: Experimental findings and molecular mechanisms. Biomed Res Int2013; 2013: 805217–805217.
68.
TresierrasMABaladyGJ. Resistance training in the treatment of diabetes and obesity: Mechanisms and outcomes. J Cardiopulm Rehabil Prev2009; 29: 67–75.
69.
Look AHEAD Research Group. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: A secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 2014; 2: 801–809.
70.
RossR. Atherosclerosis – an inflammatory disease. N Engl J Med1999; 340: 115–126.
71.
XuYAroraRCHiebertBMet al.Non-invasive endothelial function testing and the risk of adverse outcomes: A systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging2014; 15: 736–746.
72.
KingwellBA. Nitric oxide-mediated metabolic regulation during exercise: Effects of training in health and cardiovascular disease. FASEB J2000; 14: 1685–1696.
73.
NewsholmePHomem De BittencourtPICOHet al.Exercise and possible molecular mechanisms of protection from vascular disease and diabetes: The central role of ROS and nitric oxide. Clin Sci2010; 118: 341–349.
74.
SzostakJLaurantP. The forgotten face of regular physical exercise: A ‘natural’ anti-atherogenic activity. Clin Sci2011; 121: 91–106.
75.
BegotIPeixotoTCGonzagaLRet al.A home-based walking program improves erectile dysfunction in men with an acute myocardial infarction. Am J Cardiol2015; 115: 571–575.
76.
NehraAJacksonGMinerMet al.The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc2012; 87: 766–778.
77.
MusickiBBellaAJBivalacquaTJet al.Basic science evidence for the link between erectile dysfunction and cardiometabolic dysfunction. J Sex Med2015; 12: 2233–2255.
78.
ThijssenDHBlackMAPykeKEet al.Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. Am J Physiol Heart Circ Physiol2011; 300: H2–H12.
79.
BelliaAIellamoFDe CarliEet al.Exercise individualized by TRIMPi method reduces arterial stiffness in early onset type 2 diabetic patients: A randomized controlled trial with aerobic interval training. Int J Cardiol2017; 248: 314–319.
80.
AshorAWLaraJSiervoMet al.Effects of exercise modalities on arterial stiffness and wave reflection: A systematic review and meta-analysis of randomized controlled trials. PLoS One2014; 9: e110034–e110034.
81.
BureshR. Exercise and glucose control. J Sports Med Phys Fitness2014; 54: 373–382.
82.
MechanickJIZhaoSGarveyWT. The adipokine-cardiovascular-lifestyle network: Translation to clinical practice. J Am Coll Cardiol2016; 68: 1785–1803.
83.
RingseisREderKMoorenFCet al.Metabolic signals and innate immune activation in obesity and exercise. Exerc Immunol Rev2015; 21: 58–68.
HayashinoYJacksonJLFukumoriNet al.Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Diabetes Res Clin Pract2012; 98: 349–360.
86.
Van HallG. The physiological regulation of skeletal muscle fatty acid supply and oxidation during moderate-intensity exercise. Sports Med2015; 45(Suppl. 1): S23–S32.
KelleyGAKelleyKS. Effects of aerobic exercise on lipids and lipoproteins in adults with type 2 diabetes: A meta-analysis of randomized-controlled trials. Public Health2007; 121: 643–655.
89.
CatapanoALGrahamIDe BackerGet al.2016 ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis2016; 253: 281–344.
90.
MurlasitsZRadakZ. The effects of statin medications on aerobic exercise capacity and training adaptations. Sports Med2014; 44: 1519–1530.
91.
MikusCRBoyleLJBorengasserSJet al.Simvastatin impairs exercise training adaptations. J Am Coll Cardiol2013; 62: 709–714.
92.
MeexRCPhielixESchrauwen-HinderlingVBet al.The use of statins potentiates the insulin-sensitizing effect of exercise training in obese males with and without type 2 diabetes. Clin Sci2010; 119: 293–301.
93.
PlaisanceEPGrandjeanPWMahurinAJ. Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review. Phys Sportsmed2009; 37: 11–19.
94.
RuizJRSuiXLobeloFet al.Association between muscular strength and mortality in men: Prospective cohort study. BMJ2008; 337: a439–a439.
95.
Kamiya K, Masuda T, Tanaka S, et al. Quadriceps strength as a predictor of mortality in coronary artery disease. Am J Med 2015; 128(11): 1212–1219.
96.
LeongDPTeoKKRangarajanSet al.Prognostic value of grip strength: Findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet2015; 386: 266–273.
97.
GielenSSandriMKozarezIet al.Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: The randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging catabolism study. Circulation2012; 125: 2716–2727.
98.
RuasJLWhiteJPRaoRRet al.A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell2012; 151: 1319–1331.
99.
WangLMascherHPsilanderNet al.Resistance exercise enhances the molecular signaling of mitochondrial biogenesis induced by endurance exercise in human skeletal muscle. J Appl Physiol2011; 111: 1335–1344.
100.
AthertonPJBabrajJSmithKet al.Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J2005; 19: 786–788.
101.
PerkJDe BackerGGohlkeHet al.European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J2012; 33: 1635–1701.
102.
RydenLGrantPJAnkerSDet al.ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J2013; 34: 3035–3087.
103.
BuseJBGinsbergHNBakrisGLet al.Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes Association. Circulation2007; 115: 114–126.
104.
WhitlockGLewingtonSSherlikerPet al.Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet2009; 373: 1083–1096.
105.
Berrington de GonzalezAHartgePCerhanJRet al.Body-mass index and mortality among 1.46 million white adults. N Engl J Med2010; 363: 2211–2219.
106.
AdesPASavagePDTothMJet al.High-calorie-expenditure exercise: A new approach to cardiac rehabilitation for overweight coronary patients. Circulation2009; 119: 2671–2678.
107.
LavieCJMilaniRV. Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol1997; 79: 397–401.
108.
AggarwalSArenaRCudaLet al.The independent effect of traditional cardiac rehabilitation and the LEARN program on weight loss: A comparative analysis. J Cardiopulm Rehabil Prev2012; 32: 48–52.
109.
Romero-CorralAMontoriVMSomersVKet al.Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies. Lancet2006; 368: 666–678.
110.
KhalangotMTronkoMKravchenkoVet al.Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: A large prospective study in Ukraine. Heart2009; 95: 454–460.
111.
LogueJWalkerJJLeeseGet al.Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care2013; 36: 887–893.
112.
TobiasDKPanAJacksonCLet al.Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med2014; 370: 233–244.
113.
CarnethonMRDe ChavezPJBiggsMLet al.Association of weight status with mortality in adults with incident diabetes. JAMA2012; 308: 581–590.
114.
McEwenLNKarterAJWaitzfelderBEet al.Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD). Diabetes Care2012; 35: 1301–1309.
115.
DoehnerWErdmannECairnsRet al.Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population. Int J Cardiol2012; 162: 20–26.
116.
MonsUHahmannHBrennerH. A reverse J-shaped association of leisure time physical activity with prognosis in patients with stable coronary heart disease: Evidence from a large cohort with repeated measurements. Heart2014; 100: 1043–1049.
117.
McAuleyPAArteroEGSuiXet al.The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin Proc2012; 87: 443–451.
118.
GoelKThomasRJSquiresRWet al.Combined effect of cardiorespiratory fitness and adiposity on mortality in patients with coronary artery disease. Am Heart J2011; 161: 590–597.
119.
EspelandMARejeskiWJWestDSet al.Intensive weight loss intervention in older individuals: results from the Action for Health in Diabetes Type 2 diabetes mellitus trial. J Am Geriatr Soc2013; 61: 912–922.
120.
Cepeda-ValeryBPressmanGSFigueredoVMet al.Impact of obesity on total and cardiovascular mortality – fat or fiction?Nat Reviews Cardiol2011; 8: 233–237.
121.
GielenSSandriM. The obesity paradox – A scientific artifact?Int J Cardiol2013; 162: 140–142.
122.
KokkinosPMyersJFaselisCet al.BMI-mortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care2012; 35: 1021–1027.
123.
WonKBHurSHChoYKet al.Comparison of 2-year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: Results from the DIAMOND prospective cohort registry. Cardiovasc Diabetol2015; 14: 141–141.
124.
MurphyRAReindersIGarciaMEet al.Adipose tissue, muscle, and function: Potential mediators of associations between body weight and mortality in older adults with type 2 diabetes. Diabetes Care2014; 37: 3213–3219.
125.
MaillardFRoussetSPereiraBet al.High-intensity interval training reduces abdominal fat mass in postmenopausal women with type 2 diabetes. Diabetes Metabol2016; 42: 433–441.
126.
SowersJREpsteinMFrohlichED. Diabetes, hypertension, and cardiovascular disease: An update. Hypertension2001; 37: 1053–1059.
127.
LastraGSyedSKurukulasuriyaLRet al.Type 2 diabetes mellitus and hypertension: An update. Endocrinol Metab Clin North Am2014; 43: 103–122.
KudatHAkkayaVSozenABet al.Heart rate variability in diabetes patients. J Int Med Res2006; 34: 291–296.
133.
SchroederEBChamblessLELiaoDet al.Diabetes, glucose, insulin, and heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care2005; 28: 668–674.
134.
YuTYJeeJHBaeJCet al.Delayed heart rate recovery after exercise as a risk factor of incident type 2 diabetes mellitus after adjusting for glycometabolic parameters in men. Int J Cardiol2016; 221: 17–22.
135.
SydoNSydoTMerkelyBet al.Impaired heart rate response to exercise in diabetes and its long-term significance. Mayo Clin Proc2016; 91: 157–165.
136.
De FeoPSchwarzP. Is physical exercise a core therapeutical element for most patients with type 2 diabetes?Diabetes Care2013; 36(Suppl. 2): S149–S154.
137.
StephensNASparksLM. Resistance to the beneficial effects of exercise in type 2 diabetes: Are some individuals programmed to fail?J Clin Endocrinol Metab2015; 100: 43–52.
138.
BouchardCBlairSNChurchTSet al.Adverse metabolic response to regular exercise: Is it a rare or common occurrence?PLoS One2012; 7: e37887–e37887.
139.
BouchardCRankinenTTimmonsJA. Genomics and genetics in the biology of adaptation to exercise. Compr Physiol2011; 1: 1603–1648.
140.
BajpeyiSTannerCJSlentzCAet al.Effect of exercise intensity and volume on persistence of insulin sensitivity during training cessation. J Appl Physiol2009; 106: 1079–1085.
141.
SparksLMJohannsenNMChurchTSet al.Nine months of combined training improves ex vivo skeletal muscle metabolism in individuals with type 2 diabetes. J Clin Endocrinol Metab2013; 98: 1694–1702.
142.
ArmstrongMJMartinBJArenaRet al.Patients with diabetes in cardiac rehabilitation: Attendance and exercise capacity. Med Sci Sports Exerc2014; 46: 845–850.
143.
O’HaganCde VitoGBorehamCA. Exercise prescription in the treatment of type 2 diabetes mellitus: Current practices, existing guidelines and future directions. Sports Med2013; 43: 39–49.
144.
HansenDPeetersSZwaenepoelBet al.Exercise assessment and prescription in patients with type 2 diabetes in the private and home care setting: Clinical recommendations from AXXON (Belgian Physical Therapy Association). Phys Ther2013; 93: 597–610.
145.
MarwickTHHordernMDMillerTet al.Exercise training for type 2 diabetes mellitus: Impact on cardiovascular risk: A scientific statement from the American Heart Association. Circulation2009; 119: 3244–3262.
146.
ColbergSRSigalRJFernhallBet al.Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint position statement. Diabetes Care2010; 33: e147–e167.
147.
BelardinelliRLacalapriceFTianoLet al.Cardiopulmonary exercise testing is more accurate than ECG-stress testing in diagnosing myocardial ischemia in subjects with chest pain. Int J Cardiol2014; 174: 337–342.
148.
Smith-RyanAETrexlerETWingfieldHLet al.Effects of high-intensity interval training on cardiometabolic risk factors in overweight/obese women. J Sports Sci2016; 34(21): 2038–2046.
149.
LanziSCodecasaFCornacchiaMet al.Short-term HIIT and fat max training increase aerobic and metabolic fitness in men with class II and III obesity. Obesity2015; 23: 1987–1994.
150.
BalducciSZanusoSNicolucciAet al.Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: A randomized controlled trial: The Italian Diabetes and Exercise Study (IDES). Arch Intern Med2010; 170: 1794–1803.
151.
WestonKSWisloffUCoombesJS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: A systematic review and meta-analysis. Br J Sports Med2014; 48: 1227–1234.
152.
BartlettJDCloseGLMacLarenDPet al.High-intensity interval running is perceived to be more enjoyable than moderate-intensity continuous exercise: Implications for exercise adherence. J Sports Sci2011; 29: 547–553.
153.
GillenJBLittleJPPunthakeeZet al.Acute high-intensity interval exercise reduces the postprandial glucose response and prevalence of hyperglycaemia in patients with type 2 diabetes. Diabetes Obes Metab2012; 14: 575–577.
154.
LittleJPGillenJBPercivalMEet al.Low-volume high-intensity interval training reduces hyperglycemia and increases muscle mitochondrial capacity in patients with type 2 diabetes. J Appl Physiol2011; 111: 1554–1560.
155.
KarstoftKWindingKKnudsenSHet al.Mechanisms behind the superior effects of interval vs continuous training on glycaemic control in individuals with type 2 diabetes: A randomised controlled trial. Diabetologia2014; 57: 2081–2093.
156.
Hollekim-StrandSMBjorgaasMRAlbrektsenGet al.High-intensity interval exercise effectively improves cardiac function in patients with type 2 diabetes mellitus and diastolic dysfunction: A randomized controlled trial. J Am Coll Cardiol2014; 64: 1758–1760.
157.
Cassidy S, Thoma C, Hallsworth K, et al. High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: A randomised controlled trial. Diabetologia 2016; 59: 56–66.
158.
RobinsonEDurrerCSimtchoukSet al.Short-term high-intensity interval and moderate-intensity continuous training reduce leukocyte TLR4 in inactive adults at elevated risk of type 2 diabetes. J Appl Physiol2015; 119: 508–516.
159.
DuvivierBMSchaperNCHesselinkMKet al.Breaking sitting with light activities vs structured exercise: A randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes. Diabetologia2017; 60: 490–498.
160.
DempseyPCBlankenshipJMLarsenRNet al.Interrupting prolonged sitting in type 2 diabetes: Nocturnal persistence of improved glycaemic control. Diabetologia2017; 60: 499–507.
161.
HensonJDaviesMJBodicoatDHet al.Breaking up prolonged sitting with standing or walking attenuates the postprandial metabolic response in postmenopausal women: a randomized acute study. Diabetes Care2016; 39: 130–138.
162.
PanBGeLXunYQet al.Exercise training modalities in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis. Int J Behav Nutr Phys Act2018; 15: 72–72.
163.
EggerANiederseerDDiemGet al.Different types of resistance training in type 2 diabetes mellitus: Effects on glycaemic control, muscle mass and strength. Eur J Prev Cardiol2013; 20: 1051–1060.
164.
RiebeDFranklinBAThompsonPDet al.Updating ACSM’s recommendations for exercise preparticipation health screening. Med Sci Sports Exerc2015; 47: 2473–2479.
165.
HuikuriHVSteinPK. Heart rate variability in risk stratification of cardiac patients. Progr Cardiovasc Dis2013; 56: 153–159.
166.
PerlmuterLCSardaGCasavantVet al.A review of the etiology, associated comorbidities, and treatment of orthostatic hypotension. Am J Ther2013; 20: 279–291.
NaschitzJERosnerI. Orthostatic hypotension: Framework of the syndrome. Postgrad Med J2007; 83: 568–574.
169.
ShibaoCBiaggioniI. Orthostatic hypotension and cardiovascular risk. Hypertension2010; 56: 1042–1044.
170.
SigalRJKennyGPWassermanDHet al.Physical activity/exercise and type 2 diabetes: A consensus statement from the American Diabetes Association. Diabetes Care2006; 29: 1433–1438.
171.
ColbergSRVinikAI. Exercising with peripheral or autonomic neuropathy: What health care providers and diabetic patients need to know. Phys Sportsmed2014; 42: 15–23.
172.
ValensiPLorgisLCottinY. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: A review of the literature. Arch Cardiovasc Dis2011; 104: 178–188.
173.
PinaILApsteinCSBaladyGJet al.Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation2003; 107: 1210–1225.
174.
WackersFJYoungLHInzucchiSEet al.Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care2004; 27: 1954–1961.
175.
American Diabetes Association. Physical activity/exercise and diabetes. Diabetes Care2004; 27(Suppl. 1): S58–S62.
176.
BalkauBJouvenXDucimetierePet al.Diabetes as a risk factor for sudden death. Lancet1999; 354: 1968–1969.
177.
KannelWBWilsonPWD’AgostinoRBet al.Sudden coronary death in women. Am Heart J1998; 136: 205–212.
178.
ColbergSRSigalRJ. Prescribing exercise for individuals with type 2 diabetes: Recommendations and precautions. Phys Sportsmed2011; 39: 13–26.
179.
ZipesDPCammAJBorggrefeMet al.ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation2006; 114: e385–e484.
180.
CsepeTAKalyanasundaramAHansenBJet al.Fibrosis: A structural modulator of sinoatrial node physiology and dysfunction. Front Physiol2015; 6: 37–37.
181.
KannelWB. Framingham study insights on diabetes and cardiovascular disease. Clin Chem2011; 57: 338–339.
PappachanJMVarugheseGISriramanRet al.Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management. World J Diabetes2013; 4: 177–189.
184.
GrewalJMcCullyRBKaneGCet al.Left ventricular function and exercise capacity. JAMA2009; 301: 286–294.
185.
CotrimCJoaoIFazendasPet al.Clinical applications of exercise stress echocardiography in the treadmill with upright evaluation during and after exercise. Cardiovasc Ultrasound2013; 11: 26–26.
186.
Asrar Ul HaqMWongCLevingerIet al.Effect of exercise training on left ventricular remodeling in diabetic patients with diastolic dysfunction: Rationale and design. Clin Med Insights Cardiol2014; 8: 23–28.
187.
JudeEBEleftheriadouITentolourisN. Peripheral arterial disease in diabetes – a review. Diabet Med2010; 27: 4–14.
188.
ShahADLangenbergCRapsomanikiEet al.Type 2 diabetes and incidence of cardiovascular diseases: A cohort study in 1.9 million people. Lancet Diabetes Endocrinol2015; 3: 105–113.
189.
AboyansVCriquiMHAbrahamPet al.Measurement and interpretation of the ankle-brachial index: A scientific statement from the American Heart Association. Circulation2012; 126: 2890–2909.
190.
ManciaGFagardRNarkiewiczKet al.2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J2013; 34: 2159–2219.
191.
WheltonPKCareyRMAronowWSet al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation2018; 138: e484–e594.
192.
ChrysohoouCSkoumasJGeorgiopoulosGet al.Exercise capacity and haemodynamic response among 12,327 individuals with cardio-metabolic risk factors undergoing treadmill exercise. Eur J Prev Cardiol2017; 24: 1627–1636.
193.
HemmingsenBLundSSGluudCet al.Intensive glycaemic control for patients with type 2 diabetes: Systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ2011; 343: d6898–d6898.
194.
GotoAArahOAGotoMet al.Severe hypoglycaemia and cardiovascular disease: Systematic review and meta-analysis with bias analysis. BMJ2013; 347: f4533–f4533.
195.
ChowEBernjakAWilliamsSet al.Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes2014; 63: 1738–1747.
196.
InvestigatorsOTMellbinLGRydenLet al.Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. Eur Heart J2013; 34: 3137–3144.
197.
FrierBMSchernthanerGHellerSR. Hypoglycemia and cardiovascular risks. Diabetes Care2011; 34(Suppl. 2): S132–S137.
198.
PonikowskiPJankowskaEA. Hypoglycaemia in diabetic patients: Highly undesirable by cardiologists. Eur Heart J2013; 34: 3102–3105.
199.
AhrenB. Avoiding hypoglycemia: A key to success for glucose-lowering therapy in type 2 diabetes. Vasc Health Risk Manag2013; 9: 155–163.
200.
MeyerCGrossmannRMitrakouAet al.Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care1998; 21: 1960–1966.
201.
InzucchiSEBergenstalRMBuseJBet al.Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care2015; 38: 140–149.
